BioPlus Acquisition Corp.
BIOS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $15 | $40 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $115 | $86 |
| Inventory | $0 | $0 | $27 | $38 |
| Other Curr. Assets | $0 | $0 | $19 | $25 |
| Total Curr. Assets | $1 | $1 | $175 | $188 |
| Property Plant & Equip (Net) | $0 | $0 | $29 | $27 |
| Goodwill | $0 | $0 | $367 | $367 |
| Intangibles | $0 | $0 | $11 | $19 |
| Long-Term Investments | $238 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $235 | $3 | $2 |
| Total NC Assets | $238 | $235 | $409 | $415 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $238 | $236 | $584 | $603 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $67 | $66 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $39 | $38 |
| Total Curr. Liab. | $1 | $0 | $107 | $105 |
| LT Debt | $5 | $5 | $502 | $479 |
| Deferred Rev, NC | $0 | $0 | -$436 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $0 |
| Other NC Liab. | $10 | $10 | $460 | $22 |
| Total NC Liab. | $15 | $15 | $527 | $501 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $15 | $635 | $606 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $238 | $235 | $0 | $0 |
| Retained Earnings | -$15 | -$14 | -$761 | -$710 |
| AOCI | $0 | $0 | -$101 | -$88 |
| Other Equity | $0 | $0 | $811 | $795 |
| Total Equity | $223 | $221 | -$51 | -$3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $238 | $236 | $584 | $603 |
| Net Debt | $5 | $4 | $487 | $439 |